498277 Rapid Crystallization Development through Automation of Solubility Screening Coupled with XRPD

Christopher J. Morrison1, Christopher Nunn2 and Yan Sun2, (1)Particle Sciences and Engineering, GlaxoSmithKline, King of Prussia, PA, (2)GSK, King of Prussia, PA

Rapid crystallization development was enabled through a series of automated screenings using robotics to enable automated solid and liquid dispensing, solubility screening, and crystal form testing. Screenings including an initial form and rough solubility screen, followed by a 10 g screen focused on 96 solvent and antisolvent combinations at 20°C and 50°C coupled with HPLC and XRPD. Solvent and antisolvents were then selected based upon the form produced, solvent classification, and potential impurities.


Extended Abstract: File Not Uploaded
See more of this Session: Continuous Crystallization Processes
See more of this Group/Topical: Separations Division